{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:44:08Z","timestamp":1648608248813},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T00:00:00Z","timestamp":1515974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00393-017-0416-z","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T02:06:47Z","timestamp":1515982007000},"page":"80-80","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kommentar und Erg\u00e4nzung"],"prefix":"10.1007","volume":"77","author":[{"given":"Klaus L.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,15]]},"reference":[{"key":"416_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(77)90082-4","volume":"II","author":"KL Schmidt","year":"1977","unstructured":"Schmidt KL, Mueller-Eckhardt C (1977) Agranulocytosis, levamisol, and HLA-B 27. Lancet II:85","journal-title":"Lancet"},{"key":"416_CR2","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/BF01476864","volume":"56","author":"KL Schmidt","year":"1978","unstructured":"Schmidt KL, Mueller-Eckhardt C, Breithaupt H (1978) HLA-B 27, antinuclear antibodies and drug-induced agranulocytosis. Klin Wochenschr 56:1189\u20131191","journal-title":"Klin. Wochenschr."},{"key":"416_CR3","unstructured":"Ehrlich GE (1981) Pers\u00f6nlicher Brief an den Autor"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0416-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0416-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0416-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T19:35:18Z","timestamp":1547494518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0416-z"}},"subtitle":["Leukopenien und Agranulozytosen unter Antirheumatikatherapie bei HLA-B27-positiven Patienten"],"short-title":[],"issued":{"date-parts":[[2018,1,15]]},"references-count":3,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0416-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,15]]},"assertion":[{"value":"15 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L.\u00a0Schmidt gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}